Male breast cancer: patient and doctor discuss experience and treatment

submitted by: mdanderson

Male breast cancer accounts for approximately one percent of all breast cancer cases diagnosed in the United States each year. Listen to male breast cancer patient, Oliver Bogler, Ph.D.and his MD Anderson Cancer Center oncologist, Sharon Giordano, M.D., talk about male breast cancer, including the research, treatment, and Bogler’s experience as a “man in pink.”

Desmoid tumors – dangerous when not treated as cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/desmoid-tumors-dangerous-when/id4318... . Desmoid tumors, also known as "aggressive fibromatosis," develop from fibroblasts which are found throughout the body. Desmoid tumors may become life threatening when they constrict vital organs such as kidneys, lungs or intestines. Some physicians consider desmoid tumors non-cancerous since they do not metastasize, but there is a danger of undertreating. Raphael Pollock, M.D., Ph.D.,...

Environmental Engineer - Profiles of Scientists and Engineers

submitted by: nsf

What’s it really like to be an engineer or a scientist? What does an environmental engineer do all day? You’re about to find out! Meet the next generation of engineers and scientists in these profiles of young professionals, who may just inspire you to join them. Tamar Losleben shows us how environmental engineers research and plan the best ways to satisfy both human and environmental needs. Find out what it’s like to be an environmental engineer.

Learn the facts about melanoma

submitted by: mdanderson

Melanoma is on the rise in the United States. In the United States 2011, one person died of melanoma every hour. Learn to protect yourself from melanoma and know skin cancer warning signs. Ana Mercedes Ciurea, M.D., assistant professor in Dermatology at MD Anderson Cancer Center, discusses these topics as well as shares what population is most susceptible to developing melanoma.

Stereotactic body radiation therapy cancer treatment

submitted by: mdanderson
Stereotactic body radiation therapy (SBRT) differs from traditional radiation therapy for cancer patients. Treatment takes less time (four days versus seven weeks), it’s double the radiation dose and it spares the healthy tissue surrounding the tumor. SBRT is commonly used to treat lung and pancreatic cancers, as well as cancers that have spread to the liver, lung, adrenal glands and spine. Joe Chang, M.D., Ph.D., associate professor in Radiation Oncology at MD Anderson Cancer Center,...

Many Patients Continue Using Proton Pump Inhibitors After Negative Results From...

submitted by: gastro@scivee

Dr. Andrew J. Gawron discusses his manuscript "Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease." To view the print version of this abstract go to http://bit.ly/MKOYJT.

Bone Cancer Surgery Options for the Adult Patient

submitted by: mdanderson
Valerae Lewis, M.D., Associate Professor in The University of Texas MD Anderson Cancer Center Department of Orthopaedic Oncology, discusses the many surgery options for bone cancer patients. Limb salvage surgery replaces the cancerous bone with either a bone graft from another person (allowgraft), a metal implant or a combination of the two (allo-prosthetic). After amputation of the lower leg, rotationplasty moves the ankle joint to where the knee once was to function as the knee joint. MD...

Bile Duct Cancer – Rare but Numbers are Growing

submitted by: mdanderson
Download from itunes: http://itunes.apple.com/us/itunes-u/bile-duct-cancer-rare-but/id43184821... . Bile duct cancer (cholangiocarcinoma) is rare. There are 4,000 – 5,000 newly-diagnosed cases in the United States each year, and the numbers are growing. It’s important to get the disease treated at a multidisplinary facility that specializes in bile duct cancer. Thomas Aloia, M.D., Assistant Professor in Surgical Oncology; Boris Blechacz, M.D., Assistant Professor in the Department of...

Cancer Research for Stage 1 Lung Cancer

submitted by: mdanderson

New cancer research for stage 1 lung cancer is being investigated at The University of Texas MD Anderson Cancer Center. It’s led by Jack Roth, M.D., professor in the Department of Thoracic and Cardiovascular Surgery. This clinical trial called STARS (Stereotactic Radiation Therapy Verses Surgery) compares a new type of radiation treatment with a traditional surgery approach. Roth describes this promising new treatment and explains how lung cancer patients may get involved.

Young Cancer Patient Inspires Hope

submitted by: mdanderson
Shane Leonard, a talented young man with his whole life ahead of him, did not let cancer create despair. Instead, Shane looked for opportunities in his new cancer hospital surroundings to inspire his future. At 17, cancer was found in his salivary gland. After surgery, he came to The University of Texas MD Anderson Cancer Center for follow-up proton radiation treatment. In Shane's spare time, he would study quantum mechanics lectures and became friends with the senior medical physicist of...